Clearly, several components of intraperitoneal pentobarbital give cause for concern. Novel approaches, such as the use of intraperitoneal ethanol and alternative routes of injection, are promising but need more investigation to ascertain their strengths and weaknesses just before they can be proposed as ideal alternate options for, or advancements